Yigal Nochomovitz
Stock Analyst at Citigroup
(3.37)
# 2,631
Out of 5,182 analysts
341
Total ratings
46.72%
Success rate
3.74%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Maintains: Buy | $33 → $45 | $30.33 | +48.37% | 6 | Apr 24, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $276 → $282 | $241.79 | +16.63% | 3 | Apr 15, 2026 | |
| TVTX Travere Therapeutics | Maintains: Buy | $48 → $53 | $40.81 | +29.87% | 1 | Apr 14, 2026 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $204 → $242 | $128.04 | +89.00% | 4 | Apr 7, 2026 | |
| APLS Apellis Pharmaceuticals | Downgrades: Neutral | $44 → $41 | $40.95 | +0.12% | 20 | Apr 1, 2026 | |
| BMEA Biomea Fusion | Maintains: Buy | $6 → $7 | $1.73 | +304.62% | 12 | Mar 27, 2026 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $52 → $26 | $9.76 | +166.39% | 5 | Mar 26, 2026 | |
| SRPT Sarepta Therapeutics | Maintains: Sell | $9 → $13 | $20.98 | -38.04% | 3 | Mar 26, 2026 | |
| ARVN Arvinas | Maintains: Buy | $18 → $21 | $10.29 | +104.08% | 13 | Mar 19, 2026 | |
| CADL Candel Therapeutics | Maintains: Buy | $22 → $26 | $6.29 | +313.35% | 4 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $41 | $18.59 | +120.55% | 3 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $62 | $15.29 | +305.49% | 4 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $7 | $7.72 | -9.33% | 6 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $7.91 | +13.78% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.1 → $2.3 | $1.69 | +36.09% | 13 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $13.60 | +157.35% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $24.95 | +80.36% | 10 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $8 | $8.30 | -3.61% | 10 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $23.52 | +78.57% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $57 | $21.00 | +171.43% | 10 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $10.19 | +66.83% | 8 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $65 | $29.48 | +120.49% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $336 → $371 | $272.75 | +36.02% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $14 | $5.99 | +133.72% | 17 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $36 | $22.30 | +61.43% | 2 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $77 | $50.99 | +51.01% | 22 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $399 → $405 | $298.90 | +35.50% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $7.50 | +86.67% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $2.13 | +275.59% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $22.12 | +80.83% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $21.88 | +215.36% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $28.56 | -22.97% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.86 | +383.87% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $30.51 | +80.27% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $3.05 | +359.02% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $2.69 | -55.39% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.49 | +34.23% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $1.58 | +406.33% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.30 | -56.56% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $4.99 | +601.40% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $23.99 | +454.40% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $4.01 | +299.00% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.31 | +663.36% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.41 | +751.06% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $7.51 | - | 14 | Sep 28, 2021 |
ArriVent BioPharma
Apr 24, 2026
Maintains: Buy
Price Target: $33 → $45
Current: $30.33
Upside: +48.37%
Ligand Pharmaceuticals
Apr 15, 2026
Maintains: Buy
Price Target: $276 → $282
Current: $241.79
Upside: +16.63%
Travere Therapeutics
Apr 14, 2026
Maintains: Buy
Price Target: $48 → $53
Current: $40.81
Upside: +29.87%
Neurocrine Biosciences
Apr 7, 2026
Maintains: Buy
Price Target: $204 → $242
Current: $128.04
Upside: +89.00%
Apellis Pharmaceuticals
Apr 1, 2026
Downgrades: Neutral
Price Target: $44 → $41
Current: $40.95
Upside: +0.12%
Biomea Fusion
Mar 27, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $1.73
Upside: +304.62%
LENZ Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $52 → $26
Current: $9.76
Upside: +166.39%
Sarepta Therapeutics
Mar 26, 2026
Maintains: Sell
Price Target: $9 → $13
Current: $20.98
Upside: -38.04%
Arvinas
Mar 19, 2026
Maintains: Buy
Price Target: $18 → $21
Current: $10.29
Upside: +104.08%
Candel Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $22 → $26
Current: $6.29
Upside: +313.35%
Mar 17, 2026
Maintains: Buy
Price Target: $43 → $41
Current: $18.59
Upside: +120.55%
Mar 17, 2026
Maintains: Buy
Price Target: $60 → $62
Current: $15.29
Upside: +305.49%
Mar 13, 2026
Maintains: Neutral
Price Target: $4 → $7
Current: $7.72
Upside: -9.33%
Mar 11, 2026
Maintains: Buy
Price Target: $7 → $9
Current: $7.91
Upside: +13.78%
Mar 10, 2026
Maintains: Buy
Price Target: $2.1 → $2.3
Current: $1.69
Upside: +36.09%
Mar 9, 2026
Maintains: Buy
Price Target: $31 → $35
Current: $13.60
Upside: +157.35%
Mar 5, 2026
Maintains: Buy
Price Target: $44 → $45
Current: $24.95
Upside: +80.36%
Mar 4, 2026
Maintains: Neutral
Price Target: $7 → $8
Current: $8.30
Upside: -3.61%
Mar 3, 2026
Initiates: Buy
Price Target: $42
Current: $23.52
Upside: +78.57%
Mar 2, 2026
Maintains: Buy
Price Target: $51 → $57
Current: $21.00
Upside: +171.43%
Feb 24, 2026
Maintains: Buy
Price Target: $16 → $17
Current: $10.19
Upside: +66.83%
Feb 19, 2026
Maintains: Buy
Price Target: $64 → $65
Current: $29.48
Upside: +120.49%
Feb 18, 2026
Maintains: Buy
Price Target: $336 → $371
Current: $272.75
Upside: +36.02%
Jan 9, 2026
Maintains: Buy
Price Target: $11 → $14
Current: $5.99
Upside: +133.72%
Jan 6, 2026
Maintains: Buy
Price Target: $33 → $36
Current: $22.30
Upside: +61.43%
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $50.99
Upside: +51.01%
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $298.90
Upside: +35.50%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $7.50
Upside: +86.67%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $2.13
Upside: +275.59%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $22.12
Upside: +80.83%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $21.88
Upside: +215.36%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $28.56
Upside: -22.97%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $1.86
Upside: +383.87%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $30.51
Upside: +80.27%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $3.05
Upside: +359.02%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $2.69
Upside: -55.39%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.49
Upside: +34.23%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $1.58
Upside: +406.33%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.30
Upside: -56.56%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $4.99
Upside: +601.40%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $23.99
Upside: +454.40%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $4.01
Upside: +299.00%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.31
Upside: +663.36%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.41
Upside: +751.06%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $7.51
Upside: -